ChoiceSpine launches biologics line: 5 takeaways

Spinal Tech

At its national sales meeting, ChoiceSpine launched its new biologics portfolio. ChoiceSpine specializes in developing spinal products.

Here are five takeaways:

 

1. The biologics portfolio will feature various allograft and synthetic bone graft options in addition to a full amnion offering.

 

2. STRATOFUSE is designed to fuel fusion in spine and orthopedic surgical procedures. This line offers demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders.

 

3. The STRATOGEN line focuses on full amnion offering.

 

4. ChoiceSpine has pledged a portion of all biologics proceeds to be donated to the Smokey Mountain Service Dogs charitable organization. This organization is dedicated to helping wounded veterans.

 

5. Rick Henson and Marty Altshuler, co-founders of ChoiceSpine, said, "STRATOFUSE and STRATOGEN exemplify our dedication to developing and distributing spinal products that are innovative and surgeon-focused."

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers